| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/14/2000 | EP1008351A1 Carcinostatic agents |
| 06/14/2000 | EP1007736A1 Methods and compositions for modulating melting temperatures of nucleic acids |
| 06/14/2000 | EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 06/14/2000 | EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 06/14/2000 | EP1007658A2 Mdm2-specific antisense oligonucleotides |
| 06/14/2000 | EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 06/14/2000 | EP1007555A1 Tropoelastin derivatives |
| 06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
| 06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
| 06/14/2000 | EP1007533A1 Bioconjugates and delivery of bioactive agents |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1007089A1 Anticoagulant agents useful in treatment of thrombosis |
| 06/14/2000 | EP1007057A1 Method of treating herpes infections |
| 06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
| 06/14/2000 | EP0979293A4 Transcriptional silencing elements and their binding factors |
| 06/14/2000 | EP0746326A4 Oligomeric compounds having nitrogen-containing linkages |
| 06/14/2000 | EP0677057B1 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/14/2000 | CN1256312A New human glutathione peroxidase and its code sequence, preparation and use |
| 06/14/2000 | CN1053469C Production of gamma linolenic acid by delta 6-desaturase |
| 06/14/2000 | CN1053341C Use of nadh and nadph or their salts in pharmaceutic |
| 06/13/2000 | US6075185 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
| 06/13/2000 | US6074872 Nucleic acid sequence coding a nervous system polypeptide; for inducing sleep in mammals and the treatment of sleep defects; for screening potential modulators of sleep |
| 06/13/2000 | US6074862 Enzymatic polypeptide that stimulates phosphorylation of kinase; for the treatment of inflammation, autoimmune diseases and cancer; anticarcinogenic agents; bactericides |
| 06/13/2000 | US6074848 Amino acid sequence; for antiproliferative and wound healing agents |
| 06/13/2000 | US6074839 Transforming growth factor αHI |
| 06/13/2000 | US6074823 DNA sequencing by mass spectrometry via exonuclease degradation |
| 06/13/2000 | US6074820 Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping |
| 06/13/2000 | US6074818 Fingerprinting of nucleic acids, products and methods |
| 06/13/2000 | US6074642 Reduce cell lysing ability of biological complement present in blood |
| 06/13/2000 | CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 06/13/2000 | CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| 06/13/2000 | CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy |
| 06/08/2000 | WO2000033084A2 Arrays of organic compounds attached to surfaces |
| 06/08/2000 | WO2000033078A1 Porous coatings bearing ligand arrays |
| 06/08/2000 | WO2000032823A1 Dna-protein fusions and uses thereof |
| 06/08/2000 | WO2000032678A1 Solvent resistant photosensitive compositions |
| 06/08/2000 | WO2000018778A9 Synthesis of codon randomized nucleic acids |
| 06/08/2000 | WO1999013976A9 Apparatuses and methods for isolating nucleic acid |
| 06/07/2000 | EP1006186A1 Human genes |
| 06/07/2000 | EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs |
| 06/07/2000 | EP1006121A1 A universal polymer support for the synthesis of oligonucleotides |
| 06/07/2000 | EP1005573A1 Dendritic nucleic acids exhibiting maximal self-assembly |
| 06/07/2000 | EP1005572A1 Solid support with attached molecules |
| 06/07/2000 | EP1005545A1 Human extracellular matrix-1 |
| 06/07/2000 | EP1005479A1 Rna isolation reagent and methods |
| 06/07/2000 | EP1005478A1 Ribonucleoside-derivative and method for preparing the same |
| 06/07/2000 | EP1005477A2 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles |
| 06/07/2000 | EP0806965A4 Cd44 expression in smooth muscle cells |
| 06/07/2000 | CN1053195C Method for extracting chicken nucleic acid and nucleoprotein from chicken blood |
| 06/06/2000 | US6072046 Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide conjugates and reagents for making the same |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6072044 Polynucleic acid structures with at least one triangular unit; have structural rigidity necessary to serve as building block components for two and three dimensional structures |
| 06/06/2000 | US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell |
| 06/06/2000 | US6072038 Conjugates of texaphyrins |
| 06/06/2000 | US6072029 Derivatives of human α1 -antitrypsin and process for their preparation |
| 06/06/2000 | US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease |
| 06/06/2000 | US6071745 Contacting eukaryotic cells with isotonic, nuclease-free aqueous solution which has been pretreated with diethyl pyrocarbonate, lyophilizing cells, maintaining under sealed conditions |
| 06/06/2000 | US6071705 Method of detecting neurological disease or dysfunction |
| 06/06/2000 | US6071699 Nucleic acid mediated electron transfer |
| 06/06/2000 | US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell |
| 06/06/2000 | US6071533 Mixing with hydrophilic polymer to increase shelf life |
| 06/06/2000 | US6071522 Cloning of mite allergens |
| 06/06/2000 | US6071395 Process and device for isolating nucleic acids |
| 06/06/2000 | CA2203627C Rapid detection and identification of nucleic acid variants and pathogens |
| 06/06/2000 | CA1341020C Lipoprotein i (ompi) of pseudomonas aeruginosa |
| 06/06/2000 | CA1341015C Outer membrane protein f of pseudomonas aeruginosa |
| 06/06/2000 | CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 06/06/2000 | CA1341012C Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
| 06/02/2000 | WO2000031286A1 Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods |
| 06/02/2000 | WO2000031114A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION |
| 06/02/2000 | WO2000031105A1 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 06/02/2000 | WO2000031102A1 Oligonucleotide conjugation |
| 06/02/2000 | WO2000031101A1 Method for the electrochemical detection of nucleic acid oligomer hybrids |
| 06/02/2000 | WO2000030629A2 Method of promoting cervical and vaginal secretions |
| 06/02/2000 | WO2000030425A2 Method of using pon-1 to decrease atheroma formation |
| 06/02/2000 | WO2000008213A9 Oligomers which inhibit expression of collagen genes |
| 06/02/2000 | CA2352262A1 Method of promoting cervical and vaginal secretions |
| 06/02/2000 | CA2350405A1 Method of using pon-1 to decrease atheroma formation |
| 06/02/2000 | CA2345157A1 Method for electrochemically detecting nucleic acid oligomer hybrids |
| 05/31/2000 | EP1004593A2 Backbone modified oligonucleotide analogues |
| 05/31/2000 | EP1003916A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
| 05/31/2000 | EP1003908A1 Nucleic acid archiving |
| 05/31/2000 | EP1003850A1 Inhibitors of dna immunostimulatory sequence activity |
| 05/31/2000 | EP1003768A1 Secreted proteins and polynucleotides encoding them |
| 05/31/2000 | EP1003762A2 Base analogues |
| 05/31/2000 | EP1003758A2 Solution phase synthesis of oligonucleotides |
| 05/31/2000 | EP1003527A1 Polynucleotide compositions |
| 05/31/2000 | EP1003525A1 Composition and method for regulating cell proliferation and cell death |
| 05/31/2000 | EP1003480A1 Conjugated peptide nucleic acids having enhanced cellular uptake |
| 05/31/2000 | EP1003474A1 Method of treating dry eye disease with purinergic receptor agonists |
| 05/31/2000 | EP0643778B1 Encoded combinatorial chemical libraries |
| 05/31/2000 | EP0567635B1 Rapid assays for amplification products |
| 05/31/2000 | DE19852167A1 Mass spectroscopic analysis of polymorphisms or mutations in genomic DNA comprises PCR using nucleoside triphosphates which are derivatized to alter their molecular mass |
| 05/31/2000 | CN1255164A Modified antisense nucleotides complementary to section of human Ha-Ras gene |
| 05/31/2000 | CN1053012C Hog choera virus vaccine and diagnostic |
| 05/31/2000 | CN1052985C Method for extracting high-activity DNA with spike-shape relative component from Dalaicao |
| 05/30/2000 | US6069243 Process for oligonucleotide synthesis |
| 05/30/2000 | US6069140 Pharmaceutical compositions comprising texaphyrins |
| 05/30/2000 | US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants |